A documented materials audit tests more than stock levels. It asks whether each item is identified, justified, stored, handled and traceable within the research record. Sterile water and bacteriostatic water are easily treated as minor consumables, yet their status as laboratory diluents can influence the reproducibility of an in-vitro workflow and the clarity of the audit trail. Under Research Sciences’ research-use-only framework, these materials are supplied for controlled laboratory and analytical research; they are not for human or veterinary use, consumption or administration, and they must not be described or used as medicines, medical devices, injectables, treatments or food supplements.
What the Audit Must Establish About Each Diluent
Defining the diluent line
The first control is definition. Sterile water and bacteriostatic water should not be recorded under one generic “water” line. Sterile water is typically preservative-free and suited to single-use aliquots or blank and control preparations where added antimicrobial agents would compromise the assay. Bacteriostatic water is normally characterised by the presence of a bacteriostatic agent intended to inhibit microbial proliferation during repeated laboratory handling; the exact formulation must be confirmed from the supplier’s label and safety documentation, not assumed. The catalogue wording “10ml Mixing Water / Bacteriostatic Water 10ml” illustrates why the exact product title matters. An auditor should be able to see which wording was ordered, which was received, and which was used in the study.
For the wider material file, the same discipline applies to related research items. Where the study includes peptide materials, the same documentation covers related catalogue items, including Peptides uk, with the relevant batch CoA, label reference and internal test reference retained so that the diluent record is not isolated from the materials it supports. Research Sciences describes CoAs for its products, with analytical verification supporting purity, identity and contaminant screening; the researcher should open and check the CoA for the specific batch rather than relying on a general catalogue statement. Where the homepage lists “CoAs Janoshik Analytical Reports”, that is the shop’s published wording and should be reconfirmed against the live page and the batch document at the time of audit.
The audit should also record quality status. A diluent line should include product name, supplier, catalogue reference, batch or internal test reference where available, expiry, storage location, date received and the study or assay authorisation. Packaging variation, including cap colour, is not an indicator of identity, analytical quality or manufacturing origin. The audit record should instead rely on the label, CoA and controlled receiving entry. These materials remain research-use-only and are not for human or veterinary use.
Receipt, Labelling and Storage Controls That Support Traceability
Receiving and storage evidence
Receiving is where many audit gaps begin. A robust record compares the dispatch note, outer packaging, vial label and purchase order. Research Sciences describes tracked domestic fulfilment and temperature-aware storage, with orders typically dispatched the next working day and shipped via Royal Mail Tracked 24, which the shop presents as usually delivering the following working day under Royal Mail estimates. A materials audit should treat those delivery statements as published estimates to be reconfirmed, not as guarantees. At receipt, the officer should record the date, condition, quantity, exact product title and any label reference, then file the paperwork with the batch CoA where applicable.
Labelling discipline matters because water is visually indistinguishable. Sterile water and bacteriostatic water should have separate storage positions, clear product titles and reconciliation logs. If a vial label uses a reference format combining a SKU code and expiry date, that reference should be copied exactly into the audit file and quoted in any documentation query. The auditor should ask whether the material is in its original labelled container or has been aliquoted into a secondary vessel, and if so, who prepared it, when, under which procedure, and how the link to the original batch was preserved. Cap colour, vial size or shelf position should never substitute for a documented identifier.
Storage records should show compliance with the supplier’s label and safety documentation, local COSHH assessment and laboratory safety standards. The shop describes lyophilised peptides as stored at −20°C or below, sealed with desiccant and protected from moisture, heat and light, with reconstituted peptides less stable and held at 2–8°C for short-term laboratory use; those points apply to the peptide workflow, while diluent storage must follow its own label and SDS. Temperature excursions, opened containers and disposal dates should be logged as deviations. The audit should reconcile quantities received, aliquoted, consumed in in-vitro work and discarded. This is especially important where bacteriostatic water is held for repeated laboratory handling; it should not be treated as interchangeable with sterile water unless the study design and controls justify the substitution. All items remain research-use-only and are not for human or veterinary use.
Reconstitution Records and In-Vitro Documentation
Preparation records and corrective action
In an in-vitro workflow, reconstitution should be recorded as a controlled preparation step, not as an informal bench action. The record should state the diluent type, exact catalogue title, batch or internal test reference, diluent volume, intended concentration for the assay, preparation date, analyst, equipment used and any environmental or clean-working controls. If the shop’s free reconstitution calculator is used, its output should be attached to the laboratory worksheet as a calculation aid only. Research Sciences describes the calculator as being for laboratory research use only; it must not be used for human or veterinary dosing, and the materials themselves are not for human or veterinary use.
Handling notes should be reflected in the audit. Vials should be allowed to reach ambient temperature before opening in a research setting, work should be performed in a clean environment, and only the amount required for the experiment should be removed. Repeated freeze–thaw cycles should be avoided, and reconstituted material should be managed according to the study protocol and supplier guidance. For diluents, the auditor should check that sterile water was used where a preservative-free condition was required, and that bacteriostatic water was used only where the study design permitted its formulation. The record should link the diluent to the prepared sample ID, instrument run and raw data file.
A practical case is an audit finding two water containers on the same shelf with similar handwritten labels. The investigation should not rely on colour or position. It should trace purchase records, batch or internal test references, CoA documents and preparation logs to identify which container supported which assay. Corrective actions might include dedicated storage bins, controlled secondary labels, a diluent reconciliation sheet and a review of the study worksheet before data release. The audit should also confirm that the shop’s published claims, such as purity figures, order counts and CoA references, are reconfirmed against the live site and specific batch documents where they are used in internal reports. That level of documentation turns a minor diluent into an auditable material with a defensible chain from receipt to in-vitro use.
From Amman to Montreal, Omar is an aerospace engineer turned culinary storyteller. Expect lucid explainers on hypersonic jets alongside deep dives into Levantine street food. He restores vintage fountain pens, cycles year-round in sub-zero weather, and maintains a spreadsheet of every spice blend he’s ever tasted.